Carboranes as Hydrophobic Pharmacophores

Y. Endo
{"title":"Carboranes as Hydrophobic Pharmacophores","authors":"Y. Endo","doi":"10.1002/9781119275602.CH1.1","DOIUrl":null,"url":null,"abstract":"A pharmacophore is a partial structure in which important functional groups and hydrophobic structure are arranged in suitable positions for binding to a receptor [1]. Typically, hydrophilic functional groups of the pharmacophore interact with the receptor by hydrogen bonding and/or ionic bonding, and the hydrophobic structure interacts with a hydrophobic surface of the receptor. While hydrogen bonding plays a key role in specific ligand–receptor recognition, the hydrophobic interaction between receptor and drug molecule is especially important in determining the binding affinity. The difference of binding constants between a ligand having a suitable hydrophobic group and a ligand without such a group can be as large as 1000‐fold. In medicinal drug design, the hydrophobic structures are often composed of aromatic and heteroaromatic rings, which also play a role in fixing the arrangement of functional groups appropriately for binding to the receptor. On the other hand, three‐dimensional hydrophobic structures are not yet widely used in drug design, even though they could be well suited for interaction with the three‐dimensional hydrophobic binding pockets of receptors. It is noteworthy that various steroid hormones target distinct steroid hormone receptors owing to differences of functionalization of the hydrophobic steroidal skeleton. The binding of the natural ligand 17β‐estradiol to human estrogen receptor‐α (ERα) is illustrated in Figure 1.1.1 as an example. The large number of steroid hormones may be a consequence of evolutionary diversification of the functions of the steroidal skeleton. In this context, we aimed to establish a new three‐dimensional hydrophobic skeletal structure for medicinal drug design. Carboranes as Hydrophobic Pharmacophores: Applications for Design of Nuclear Receptor Ligands","PeriodicalId":124832,"journal":{"name":"Boron-Based Compounds","volume":"71 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Boron-Based Compounds","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/9781119275602.CH1.1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4

Abstract

A pharmacophore is a partial structure in which important functional groups and hydrophobic structure are arranged in suitable positions for binding to a receptor [1]. Typically, hydrophilic functional groups of the pharmacophore interact with the receptor by hydrogen bonding and/or ionic bonding, and the hydrophobic structure interacts with a hydrophobic surface of the receptor. While hydrogen bonding plays a key role in specific ligand–receptor recognition, the hydrophobic interaction between receptor and drug molecule is especially important in determining the binding affinity. The difference of binding constants between a ligand having a suitable hydrophobic group and a ligand without such a group can be as large as 1000‐fold. In medicinal drug design, the hydrophobic structures are often composed of aromatic and heteroaromatic rings, which also play a role in fixing the arrangement of functional groups appropriately for binding to the receptor. On the other hand, three‐dimensional hydrophobic structures are not yet widely used in drug design, even though they could be well suited for interaction with the three‐dimensional hydrophobic binding pockets of receptors. It is noteworthy that various steroid hormones target distinct steroid hormone receptors owing to differences of functionalization of the hydrophobic steroidal skeleton. The binding of the natural ligand 17β‐estradiol to human estrogen receptor‐α (ERα) is illustrated in Figure 1.1.1 as an example. The large number of steroid hormones may be a consequence of evolutionary diversification of the functions of the steroidal skeleton. In this context, we aimed to establish a new three‐dimensional hydrophobic skeletal structure for medicinal drug design. Carboranes as Hydrophobic Pharmacophores: Applications for Design of Nuclear Receptor Ligands
碳硼烷作为疏水性药效团
药效团是一种部分结构,其中重要的官能团和疏水结构排列在合适的位置以与受体结合[1]。通常,药效团的亲水性官能团通过氢键和/或离子键与受体相互作用,疏水结构与受体的疏水表面相互作用。虽然氢键在特定的配体-受体识别中起着关键作用,但受体与药物分子之间的疏水相互作用在决定结合亲和力方面尤为重要。具有疏水性基团的配体与没有疏水性基团的配体的结合常数相差可达1000倍。在药物设计中,疏水结构通常由芳香环和杂芳香环组成,它们也起着固定官能团的排列以与受体结合的作用。另一方面,尽管三维疏水结构可以很好地与受体的三维疏水结合袋相互作用,但它们尚未广泛应用于药物设计。值得注意的是,由于疏水甾体骨架功能化的差异,各种类固醇激素靶向不同的类固醇激素受体。天然配体17β -雌二醇与人雌激素受体α (ERα)的结合如图1.1.1所示。大量的类固醇激素可能是类固醇骨骼功能进化多样化的结果。在这种情况下,我们的目标是建立一个新的三维疏水骨架结构用于药物设计。碳硼烷作为疏水性药物载体:在核受体配体设计中的应用
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信